Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05934708 · ClinicalTrials.gov registry record · NA

Examining the Role of Female Endogenous Sex Hormones in Eccentric Exercise

A NA study of Inflammatory Response, sponsored by University of Southern California.

Recruiting
Registry status
NA
Development phase
30
Enrollment target
1
Study location

NCT05934708 is a NA study of Inflammatory Response that is actively recruiting participants, run by University of Southern California. The registered enrollment target is 30 participants, below the 176-participant average among 16 other Inflammatory Response trials with a reported enrollment target (83% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05934708, a NA study of Inflammatory Response, is actively recruiting participants, sponsored by University of Southern California.

RECRUITING
Registry status
NA
Development phase
30 participants
Enrollment target
1
Study location

Study Summary

The fluctuating concentrations of female sex hormones, namely estrogen and progesterone may have an effect on the ability of the tissue to withstand challenging exercise conditions, such as eccentric exercise. These sex hormones have also been purported to influence the perceived difficulty of exercise. This study aims to uncover how the different estrogen and progesterone concentrations present throughout the menstrual cycle effect perceived readiness to perform, perceptions of difficulty, and different recovery metrics.

Conditions Studied

Interventions

  • BEHAVIORAL Eccentric leg extension

Study Locations (1)

California

  • Clinical Exercise Research Center - Los Angeles

Trial Details

FieldValue
Enrollment Target 30 participants
Start Date 2025-03-07
Est. Completion 2026-08
Phase NA

Sponsor

University of Southern California

617 total trials

What the Registry Record Tells You About NCT05934708

The ClinicalTrials.gov registry entry for NCT05934708 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 30 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 176-participant average among 16 other Inflammatory Response trials with a reported enrollment target (83% lower). The listed sponsor is University of Southern California, which has 617 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Inflammatory Response appearing as the primary indexed condition, and to 1 intervention - of which Eccentric leg extension is the first listed.

NCT05934708 reports 1 study location spanning 1 distinct geographic area - top geographies include California.

Frequently Asked Questions

What is clinical trial NCT05934708 about?

NCT05934708 is a clinical study titled "Examining the Role of Female Endogenous Sex Hormones in Eccentric Exercise". The fluctuating concentrations of female sex hormones, namely estrogen and progesterone may have an effect on the ability of the tissue to withstand challenging exercise conditions, such as eccentric exercise. These sex hormones have also been purported to influence the perceived difficulty of exerc...

What is the current status of trial NCT05934708?

This trial is currently recruiting. It is a NA study. The enrollment target is 30 participants. The study started on 2025-03-07. Estimated completion is 2026-08.

What conditions does trial NCT05934708 study?

This clinical trial studies the following conditions: Inflammatory Response.

What interventions are being tested in trial NCT05934708?

The interventions under investigation include: Eccentric leg extension (BEHAVIORAL).

Who is sponsoring clinical trial NCT05934708?

This trial is sponsored by University of Southern California, which has 617 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05934708 being conducted?

This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Inflammatory Response

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.